Jointown Pharmaceutical Group Co (SHSE:600998) Cash Flow for Dividends: ¥-1,463 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600998 Jointown Pharmaceutical Group Co Ltd SHSE:600998
81 GF Score
Price ¥5.12
GF Value ¥5.58
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Jointown Pharmaceutical Group Co Cash Flow for Dividends?

Jointown Pharmaceutical Group Co SHSE:600998 +1.99% 81 Cash Flow for Dividends is ¥-1,463 Mil as of Mar. 2026. GuruFocus rates SHSE:600998 with a GF Score™ of 81/100 and a GF Value™ of ¥5.58 (Fairly Valued). The stock has 6 warning signs investors should review.

Jointown Pharmaceutical Group Co's cash flow for dividends for the three months ended in Mar. 2026 was ¥-94 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2026 was ¥-1,463 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Jointown Pharmaceutical Group Co's quarterly payment of dividends declined from Sep. 2025 (¥-214 Mil) to Dec. 2025 (¥-62 Mil) but then increased from Dec. 2025 (¥-62 Mil) to Mar. 2026 (¥-94 Mil).

Jointown Pharmaceutical Group Co's annual payment of dividends declined from Dec. 2023 (¥-1,635 Mil) to Dec. 2024 (¥-1,554 Mil) and declined from Dec. 2024 (¥-1,554 Mil) to Dec. 2025 (¥-1,479 Mil).

Jointown Pharmaceutical Group Co Cash Flow for Dividends Related Terms

Jointown Pharmaceutical Group Co Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Jointown Pharmaceutical Group Co's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jointown Pharmaceutical Group Co Cash Flow for Dividends Chart

Jointown Pharmaceutical Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,681.66 -1,388.09 -1,634.76 -1,553.51 -1,479.48

Jointown Pharmaceutical Group Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -110.59 -1,093.03 -214.22 -61.64 -94.47
SHSE:600998
81GF Score
Jointown Pharmaceutical Group Co Ltd SHSE:600998
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jointown Pharmaceutical Group Co Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-1,463 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of ¥-1,463 Mil mean?
Jointown Pharmaceutical Group Co (SHSE:600998) has a Cash Flow for Dividends of ¥-1,463 Mil as of Mar. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Jointown Pharmaceutical Group Co and its competitors.
Is Jointown Pharmaceutical Group Co's Cash Flow for Dividends too high?
Jointown Pharmaceutical Group Co's current Cash Flow for Dividends is ¥-1,463 Mil. Overall, Jointown Pharmaceutical Group Co has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Jointown Pharmaceutical Group Co's Cash Flow for Dividends compare to MCK and COR?
Jointown Pharmaceutical Group Co's Cash Flow for Dividends of ¥-1,463 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Medical Distribution company?
A good Cash Flow for Dividends depends on the Medical Distribution industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Jointown Pharmaceutical Group Co and its competitors. Jointown Pharmaceutical Group Co's current Cash Flow for Dividends is ¥-1,463 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jointown Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Jointown Pharmaceutical Group Co (SHSE:600998) is currently considered Fairly Valued. The stock's GF Value™ is ¥5.58, compared to a current price of ¥5.12 — trading 8.2% below its estimated fair value. The current Cash Flow for Dividends is ¥-1,463 Mil. Jointown Pharmaceutical Group Co's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Jointown Pharmaceutical Group Co (SHSE:600998), the current Cash Flow for Dividends is ¥-1,463 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jointown Pharmaceutical Group Co (SHSE:600998) Overvalued in 2026?

Based on GuruFocus' analysis, Jointown Pharmaceutical Group Co stock appears to be undervalued. The current stock price of ¥5.12 is trading 8.2% below its estimated GF Value™ of ¥5.58. GuruFocus considers Jointown Pharmaceutical Group Co to be Fairly Valued.

Key valuation signals for SHSE:600998:

  • Cash Flow for Dividends: ¥-1,463 Mil
  • GF Value™: ¥5.58 vs. price of ¥5.12 (8.2% below fair value)
  • GF Score™: 81/100 with 6 warning signs

No single metric tells the full story. See the SHSE:600998 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jointown Pharmaceutical Group Co Business Description

Address No. 5, Longxing West Street, Hanyang District, Hubei Province, Wuhan, CHN, 430051
Jointown Pharmaceutical Group Co Ltd is engaged in the business of wholesaling drugs and medical devices. The company offers logistics and other value-added services and mainly serves medical institutions, wholesale enterprises, and retail pharmacies.
81GF Score

Get the complete analysis for SHSE:600998

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥5.12
Price
¥5.58
GF Value